{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T09:53:39Z","timestamp":1778925219692,"version":"3.51.4"},"reference-count":53,"publisher":"Japanese Society for Lymphoreticular Tissue Research","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Exp Hematopathol","JCEH"],"published-print":{"date-parts":[[2014]]},"DOI":"10.3960\/jslrt.54.23","type":"journal-article","created":{"date-parts":[[2014,6,17]],"date-time":"2014-06-17T23:13:54Z","timestamp":1403046834000},"page":"23-30","source":"Crossref","is-referenced-by-count":23,"title":["Molecular Pathogenesis of Follicular Lymphoma"],"prefix":"10.3960","volume":"54","author":[{"given":"Wataru","family":"Kishimoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Momoko","family":"Nishikori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2349","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Zelenetz AD, Chu G, Galili N, Bangs CD, Horning SJ, <I>et al<\/I>.: Enhanced detection of the t(14;18) translocation in malignant lymphoma using pulsed-field gel electrophoresis. Blood 78:1552-1560, 1991","DOI":"10.1182\/blood.V78.6.1552.1552"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Weiss LM, Warnke RA, Sklar J, Cleary ML: Molecular analysis of the t(14;18) chromosomal translocation in malignant lymphomas. N Engl J Med 317:1185-1189, 1987","DOI":"10.1056\/NEJM198711053171904"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Tsujimoto Y, Gorham J, Cossman J, Jaffe E, Croce CM: The t(14;18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining. Science 229:1390-1393, 1985","DOI":"10.1126\/science.3929382"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Cleary ML, Sklar J: Nucleotide sequence of a t(14;18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint-cluster region near a transcriptionally active locus on chromosome 18. Proc Natl Acad Sci USA 82:7439-7443, 1985","DOI":"10.1073\/pnas.82.21.7439"},{"key":"5","unstructured":"5 Bakhshi A, Jensen JP, Goldman P, Wright JJ, McBride OW, <I>et al<\/I>.: Cloning the chromosomal breakpoint of t(14;18) human lymphomas: clustering around JH on chromosome 14 and near a transcriptional unit on 18. Cell 41:899-906, 1985"},{"key":"6","unstructured":"6 Summers KE, Goff LK, Wilson AG, Gupta RK, Lister TA, <I>et al<\/I>.: Frequency of the <I>Bcl<\/I>-<I>2\/IgH<\/I> rearrangement in normal individuals: implications for the monitoring of disease in patients with follicular lymphoma. J Clin Oncol 19:420-424, 2001"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Yasukawa M, Bando S, D&ouml;lken G, Sada E, Yakushijin Y, <I>et al<\/I>.: Low frequency of <I>BCL<\/I>-<I>2\/JH<\/I> translocation in peripheral blood lymphocytes of healthy Japanese individuals. Blood 98:486-488, 2001","DOI":"10.1182\/blood.V98.2.486"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Sch&uuml;ler F, Hirt C, D&ouml;lken G: Chromosomal translocation t(14;18) in healthy individuals. Sem Cancer Biol 13:203-209, 2003","DOI":"10.1016\/S1044-579X(03)00016-6"},{"key":"9","unstructured":"9 Schmitt C, Balogh B, Grundt A, Buchholtz C, Leo A, <I>et al<\/I>.: The <I>bcl<\/I>-<I>2\/IgH<\/I> rearrangement in a population of 204 healthy individuals: occurrence, age and gender distribution, breakpoints, and detection method validity. Leuk Res 30:745-750, 2006"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Kridel R, Sehn LH, Gascoyne RD: Pathogenesis of follicular lymphoma. J Clin Invest 122:3424-3431, 2012","DOI":"10.1172\/JCI63186"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Horsman DE, Connors JM, Pantzar T, Gascoyne RD: Analysis of secondary chromosomal alterations in 165 cases of follicular lymphoma with t(14;18). Genes Chromosomes Cancer 30:375-382, 2001","DOI":"10.1002\/gcc.1103"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Johansson B, Mertens F, Mitelman F: Cytogenetic evolution patterns in non-Hodgkin's lymphoma. Blood 86:3905-3914, 1995","DOI":"10.1182\/blood.V86.10.3905.bloodjournal86103905"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 H&ouml;glund M, Sehn L, Connors JM, Gascoyne RD, Siebert R, <I>et al<\/I>.: Identification of cytogenetic subgroups and karyotypic pathways of clonal evolution in follicular lymphomas. Genes Chromosomes Cancer 39:195-204, 2004","DOI":"10.1002\/gcc.10314"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Viardot A, M&ouml;ller P, H&ouml;gel J, Werner K, Mechtersheimer G, <I>et al<\/I>.: Clinicopathologic correlations of genomic gains and losses in follicular lymphoma. J Clin Oncol 20:4523-4530, 2002","DOI":"10.1200\/JCO.2002.12.006"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Cheung KJ, Shah SP, Steidl C, Johnson N, Relander T, <I>et al<\/I>.: Genome-wide profiling of follicular lymphoma by array comparative genomic hybridization reveals prognostically significant DNA copy number imbalances. Blood 113:137-148, 2009","DOI":"10.1182\/blood-2008-02-140616"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Cheung KJ, Johnson NA, Affleck JG, Severson T, Steidl C, <I>et al<\/I>.: Acquired TNFRSF14 mutations in follicular lymphoma are associated with worse prognosis. Cancer Res 70:9166-9174, 2010","DOI":"10.1158\/0008-5472.CAN-10-2460"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Launay E, Pangault C, Bertrand P, Jardin F, Lamy T, <I>et al<\/I>.: High rate of TNFRSF14 gene alterations related to 1p36 region in <I>de novo<\/I> follicular lymphoma and impact on prognosis. Leukemia 26:559-562, 2012","DOI":"10.1038\/leu.2011.266"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Oricchio E, Nanjangud G, Wolfe AL, Schatz JH, Mavrakis KJ, <I>et al<\/I>.: The Eph-receptor A7 is a soluble tumor suppressor for follicular lymphoma. Cell 147:554-564, 2011","DOI":"10.1016\/j.cell.2011.09.035"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Egle A, Harris AW, Bath ML, O'Reilly L, Cory S: VavP-<I>Bcl<\/I><I>2<\/I> transgenic mice develop follicular lymphoma preceded by germinal center hyperplasia. Blood 103:2276-2283, 2004","DOI":"10.1182\/blood-2003-07-2469"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Morin RD, Johnson NA, Severson TM, Mungall AJ, An J, <I>et al<\/I>. Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin. Nat Genet 42:181-185, 2010","DOI":"10.1038\/ng.518"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 B&eacute;guelin W, Popovic R, Teater M, Jiang Y, Bunting KL, <I>et al<\/I>.: EZH2 is required for germinal center formation and somatic EZH2 mutations promote lymphoid transformation. Cancer Cell 23:677-692, 2013","DOI":"10.1016\/j.ccr.2013.04.011"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Pasqualucci L, Dominguez-Sola D, Chiarenza A, Fabbri G, Grunn A, <I>et al<\/I>.: Inactivating mutations of acetyltransferase genes in B-cell lymphoma. Nature 471:189-195, 2011","DOI":"10.1038\/nature09730"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Morin RD, Mendez-Lago M, Mungall AJ, Goya R, Mungall KL, <I>et al<\/I>.: Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma. Nature 476:298-303, 2011","DOI":"10.1038\/nature10351"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Limpens J, Stad R, Vos C, de Vlaam C, de Jong D, van Ommen GJ, <I>et al<\/I>.: Lymphoma-associated translocation t(14;18) in blood B cells of normal individuals. Blood 85:2528-2536, 1995.","DOI":"10.1182\/blood.V85.9.2528.bloodjournal8592528"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 D&ouml;lken G, Illerhaus G, Hirt C, Mertelsmann R: <I>BCL<\/I>-<I>2\/JH<\/I> rearrangements in circulating B cells of healthy blood donors and patients with nonmalignant diseases. J Clin Oncol 14:1333-1344, 1996","DOI":"10.1200\/JCO.1996.14.4.1333"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Agopian J, Navarro JM, Gac AC, Lecluse Y, Briand M, <I>et al<\/I>.: Agricultural pesticide exposure and the molecular connection to lymphomagenesis. J Exp Med 206:1473-1483, 2009","DOI":"10.1084\/jem.20082842"},{"key":"27","unstructured":"27 Cong P, Raffeld M, Teruya-Feldstein J, Sorbara L, Pittaluga S, <I>et al<\/I>.: <I>In situ<\/I> localization of follicular lymphoma: description and analysis by laser capture microdissection. Blood 99:3376-3382, 2002"},{"key":"28","unstructured":"28 Jegalian AG, Eberle FC, Pack SD, Mirvis M, Raffeld M, <I>et al<\/I>.: Follicular lymphoma <I>in situ<\/I>: clinical implications and comparisons with partial involvement by follicular lymphoma. Blood 118:2976-2984, 2011"},{"key":"29","unstructured":"29 Cheung MC, Bailey D, Pennell N, Imrie KR, Berinstein NL, <I>et al<\/I>.: <I>In situ<\/I> localization of follicular lymphoma: evidence for subclinical systemic disease with detection of an identical <I>BCL<\/I>-<I>2\/IGH<\/I> fusion gene in blood and lymph node. Leukemia 23:1176-1179, 2009"},{"key":"30","unstructured":"30 Roulland S, Navarro JM, Grenot P, Milili M, Agopian J, <I>et al<\/I>.: Follicular lymphoma-like B cells in healthy individuals: a novel intermediate step in early lymphomagenesis. J Exp Med 203:2425-2431, 2006"},{"key":"31","unstructured":"31 Vaandrager JW, Schuuring E, Kluin-Nelemans HC, Dyer MJ, Raap AK, <I>et al<\/I>.: DNA fiber fluorescence <I>in situ<\/I> hybridization analysis of immunoglobulin class switching in B-cell neoplasia: aberrant <I>CH<\/I> gene rearrangements in follicle center-cell lymphoma. Blood 92:2871-2878, 1998"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32 Akasaka T, Akasaka H, Yonetani N, Ohno H, Yamabe H, <I>et al<\/I>.: Refinement of the <I>BCL2\/immunoglobulin heavy chain<\/I> fusion gene in t(14;18)(q32;q21) by polymerase chain reaction amplification for long targets. Genes Chromosomes Cancer 21:17-29, 1998","DOI":"10.1002\/(SICI)1098-2264(199801)21:1<17::AID-GCC4>3.0.CO;2-B"},{"key":"33","unstructured":"33 Harris NL, Jaffe ES, Stein H, Banks PM, Chan JK, <I>et al<\/I>.: A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 84:1361-1392, 1994"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34 Carlotti E, Wrench D, Matthews J, Iqbal S, Davies A, <I>et al<\/I>.: Transformation of follicular lymphoma to diffuse large B-cell lymphoma may occur by divergent evolution from a common progenitor cell or by direct evolution from the follicular lymphoma clone. Blood 113:3553-3557, 2009","DOI":"10.1182\/blood-2008-08-174839"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35 Eide MB, Liest&oslash;l K, Lingjaerde OC, Hystad ME, Kresse SH, <I>et al<\/I>.: Genomic alterations reveal potential for higher grade transformation in follicular lymphoma and confirm parallel evolution of tumor cell clones. Blood 116:1489-1497, 2010","DOI":"10.1182\/blood-2010-03-272278"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36 Green MR, Gentles AJ, Nair RV, Irish JM, Kihira S, <I>et al<\/I>.: Hierarchy in somatic mutations arising during genomic evolution and progression of follicular lymphoma. Blood 121:1604-1611, 2013","DOI":"10.1182\/blood-2012-09-457283"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37 Roulland S, Suarez F, Hermine O, Nadel B: Pathophysiological aspects of memory B-cell development. Trends Immunol 29:25-033, 2008","DOI":"10.1016\/j.it.2007.10.005"},{"key":"38","unstructured":"38 Dave SS, Wright G, Tan B, Rosenwald A, Gascoyne RD, <I>et al<\/I>.: Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. N Engl J Med 351:2159-2169, 2004"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39 Carreras J, Lopez-Guillermo A, Fox BC, Colomo L, Martinez A, <I>et al<\/I>.: High numbers of tumor-infiltrating FOXP3-positive regulatory T cells are associated with improved overall survival in follicular lymphoma. Blood 108:2957-2964, 2006","DOI":"10.1182\/blood-2006-04-018218"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40 Lee AM, Clear AJ, Calaminici M, Davies AJ, Jordan S, <I>et al<\/I>.: Number of CD4<SUP>+<\/SUP> cells and location of forkhead box protein P3-positive cells in diagnostic follicular lymphoma tissue microarrays correlates with outcome. J Clin Oncol 24:5052-5059, 2006","DOI":"10.1200\/JCO.2006.06.4642"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41 Farinha P, Al-Tourah A, Gill K, Klasa R, Connors JM, <I>et al<\/I>.: The architectural pattern of FOXP3-positive T cells in follicular lymphoma is an independent predictor of survival and histologic transformation. Blood 115:289-295, 2010","DOI":"10.1182\/blood-2009-07-235598"},{"key":"42","unstructured":"42 Wahlin BE, Aggarwal M, Montes-Moreno S, Gonzalez LF, Roncador G, <I>et al<\/I>.: A unifying microenvironment model in follicular lymphoma: outcome is predicted by programmed death-1-positive, regulatory, cytotoxic, and helper T cells and macrophages. Clin Cancer Res 16:637-650, 2010"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43 Carreras J, Lopez-Guillermo A, Roncador G, Villamor N, Colomo L, <I>et al<\/I>.: High numbers of tumor-infiltrating programmed cell death 1-positive regulatory lymphocytes are associated with improved overall survival in follicular lymphoma. J Clin Oncol 27:1470-1476, 2009","DOI":"10.1200\/JCO.2008.18.0513"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44 Farinha P, Masoudi H, Skinnider BF, Shumansky K, Spinelli JJ, <I>et al<\/I>.: Analysis of multiple biomarkers shows that lymphoma-associated macrophage (LAM) content is an independent predictor of survival in follicular lymphoma (FL). Blood 106:2169-2174, 2005","DOI":"10.1182\/blood-2005-04-1565"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45 Byers RJ, Sakhinia E, Joseph P, Glennie C, Hoyland JA, <I>et al<\/I>.: Clinical quantitation of immune signature in follicular lymphoma by RT-PCR-based gene expression profiling. Blood 111:4764-4770, 2008","DOI":"10.1182\/blood-2007-10-115915"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46 Canioni D, Salles G, Mounier N, Brousse N, Keuppens M, <I>et al<\/I>.: High numbers of tumor-associated macrophages have an adverse prognostic value that can be circumvented by rituximab in patients with follicular lymphoma enrolled onto the GELA-GOELAMS FL-2000 trial. J Clin Oncol 26:440-446, 2008","DOI":"10.1200\/JCO.2007.12.8298"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47 Taskinen M, Karjalainen-Lindsberg ML, Leppa S: Prognostic influence of tumor-infiltrating mast cells in patients with follicular lymphoma treated with rituximab and CHOP. Blood 111:4664-4667, 2008","DOI":"10.1182\/blood-2007-11-125823"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48 Clear AJ, Lee AM, Calaminici M, Ramsay AG, Morris KJ, <I>et al<\/I>.: Increased angiogenic sprouting in poor prognosis FL is associated with elevated numbers of CD163<SUP>+<\/SUP> macrophages within the immediate sprouting microenvironment. Blood 115:5053-5056, 2010","DOI":"10.1182\/blood-2009-11-253260"},{"key":"49","unstructured":"49 Pangault C, Am&eacute;-Thomas P, Ruminy P, Rossille D, Caron G, <I>et al<\/I>.: Follicular lymphoma cell niche: identification of a preeminent IL-4-dependent T<SUB>FH<\/SUB>-B cell axis. Leukemia 24:2080-2089, 2010"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50 Guilloton F, Caron G, Menard C, Pangault C, Ame-Thomas P, <I>et al<\/I>.: Mesenchymal stromal cells orchestrate follicular lymphoma cell niche through the CCL2-dependent recruitment and polarization of monocytes. Blood 119:2556-2567, 2012","DOI":"10.1182\/blood-2011-08-370908"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51 Zhu D, McCarthy H, Ottensmeier CH, Johnson P, Hamblin TJ, <I>et al<\/I>.: Acquisition of potential N-glycosylation sites in the immunoglobulin variable region by somatic mutation is a distinctive feature of follicular lymphoma. Blood 99:2562-2568, 2002","DOI":"10.1182\/blood.V99.7.2562"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52 McCann KJ, Ottensmeier CH, Callard A, Radcliffe CM, Harvey DJ, <I>et al<\/I>.: Remarkable selective glycosylation of the immunoglobulin variable region in follicular lymphoma. Mol Immunol 45:1567-1572, 2008","DOI":"10.1016\/j.molimm.2007.10.009"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53 Coelho V, Krysov S, Ghaemmaghami AM, Emara M, Potter KN, <I>et al<\/I>.: Glycosylation of surface Ig creates a functional bridge between human follicular lymphoma and microenvironmental lectins. Proc Natl Acad Sci USA 107:18587-18592, 2010","DOI":"10.1073\/pnas.1009388107"}],"container-title":["Journal of Clinical and Experimental Hematopathology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T10:02:17Z","timestamp":1689328937000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/54\/1\/54_23\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.3960\/jslrt.54.23","relation":{},"ISSN":["1346-4280","1880-9952"],"issn-type":[{"value":"1346-4280","type":"print"},{"value":"1880-9952","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]}}}